Cargando…

The extent of metalloproteinase-mediated LAG3 cleavage limits the efficacy of PD1 blockade

Detalles Bibliográficos
Autores principales:	Andrews, Lawrence P, Szymczak-Workman, Andrea L, Workman, Creg J, Vignali, Dario AA
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649300/ http://dx.doi.org/10.1186/2051-1426-3-S2-P216

Ejemplares similares

Remodulation of the tumor microenvironment by regulatory T cells
por: Liu, Chang, et al.
Publicado: (2015)

Modulation of Redox Balance Leaves Murine Diabetogenic TH1 T Cells “LAG-3-ing” Behind
por: Delmastro, Meghan M., et al.
Publicado: (2012)

Kinetics of Alloantigen-Specific Regulatory CD4 T Cell Development and Tissue Distribution After Donor-Specific Transfusion and Costimulatory Blockade
por: Tomita, Yusuke, et al.
Publicado: (2016)

Lymphocyte Activation Gene-3 (LAG-3) Negatively Regulates Environmentally-Induced Autoimmunity
por: Jha, Vibha, et al.
Publicado: (2014)

Neuropilin-1: a checkpoint target with unique implications for cancer immunology and immunotherapy
por: Chuckran, Christopher A, et al.
Publicado: (2020)

Neuropilin-1 is a T cell memory checkpoint limiting long-term anti-tumor immunity
por: Liu, Chang, et al.
Publicado: (2020)

Regulatory T Cells: Barriers of Immune Infiltration Into the Tumor Microenvironment
por: Scott, Ellen N., et al.
Publicado: (2021)

Combinatorial Immunotherapy: PD-1 may not be LAG-ing behind any more
por: Turnis, Meghan E., et al.
Publicado: (2012)

Preclinical to clinical translation of anti-PD-1 blockade
por: Hirsch, Heather, et al.
Publicado: (2015)

Autoreactive CD8(+) T cells are restrained by an exhaustion-like program that is maintained by LAG3
por: Grebinoski, Stephanie, et al.
Publicado: (2022)

T cell activation and anti-tumor efficacy of anti-LAG-3 antibodies is independent of LAG-3 – MHCII blocking capacity
por: Cemerski, Saso, et al.
Publicado: (2015)

Radiotherapy induces responsiveness of a resistant mammary carcinoma to PD-1 blockade
por: Diamond, Julie, et al.
Publicado: (2014)

MAP kinase inhibitors stimulate T cell and anti-tumor activity in combination with blockade of the PD-L1/PD-1 interaction
por: Irving, Bryan A, et al.
Publicado: (2013)

PD-1 and LAG-3 blockade improve anti-tumor vaccine efficacy
por: Zahm, Christopher D., et al.
Publicado: (2021)

Zero-lag synchronization in cortical motifs
por: Gollo, Leonardo L, et al.
Publicado: (2013)

Elucidating the role of Neuropilin-1 in intra-tumoral regulatory T cell stability
por: Overacre, Abigail E, et al.
Publicado: (2015)

Innate resistance of PD-1 blockade through loss of function mutations in JAK resulting in inability to express PD-L1 upon interferon exposure
por: Shin, Daniel, et al.
Publicado: (2015)

Regulatory T Cell–Derived TRAIL Is Not Required for Peripheral Tolerance
por: Dadey, Rebekah E., et al.
Publicado: (2021)

Electrocardiographic markers of myocardial infarction size, transmural extent, and extent of nonviable myocardium - comparison to CMR
por: Lee, Daniel C, et al.
Publicado: (2016)

PD-1 blockade reverses viral infection-induced loss of anti-tumor CD8+ T cell responses
por: Huelsmann, Erica, et al.
Publicado: (2013)

Compensatory upregulation of PD-1, LAG-3, and CTLA-4 limits the efficacy of single-agent checkpoint blockade in metastatic ovarian cancer
por: Huang, Ruea-Yea, et al.
Publicado: (2016)

Variable density of CD8+ and CD25+ programmed cell death-1 (PD-1) ligand (PD-L1) CD4+ T cells within the tumor microenvironment causes differential responses to the PD-1/PD-L1 blockade
por: Wu, Si-Pei, et al.
Publicado: (2015)

Enhanced anti-tumor effects of the PD-1/PD-L1 blockade by combining a highly absorptive form of NF-kB/STAT3 inhibitor curcumin
por: Hayakawa, Taeko, et al.
Publicado: (2014)

Improved anti-tumor immunity and efficacy upon combination of the IDO1 inhibitor GDC-0919 with anti-PD-l1 blockade versus anti-PD-l1 alone in preclinical tumor models
por: Spahn, Jessica, et al.
Publicado: (2015)

Selinexor, a selective inhibitor of nuclear export (SINE), shows enhanced activity in combination with PD-1/PD-L1 blockade in syngeneic murine models of colon cancer and melanoma
por: Farren, Matthew R, et al.
Publicado: (2015)

PD-1 blockade upregulate TIM-3 expression as a compensatory regulation of immune check point receptors in HNSCC TIL
por: Shayan, Gulidanna, et al.
Publicado: (2015)

Increased concentration of serum soluble LAG3 in systemic lupus erythematosus
por: Yu, Seri, et al.
Publicado: (2012)

Zero-lag long-range synchronization via hippocampal dynamical relaying
por: Gollo, Leonardo L, et al.
Publicado: (2010)

Reconstructing the directionality of coupling between cortical populations with negative phase lag
por: Matias, Fernanda S, et al.
Publicado: (2015)

Sequential tumor and dual immune targeted immunotherapy: anti-lymphoma activity of Rituximab with 4-1bb stimulation and PD-1 blockade
por: Mueller, Antonia MS, et al.
Publicado: (2014)

Relationship between immune gene signatures and clinical response to PD-1 blockade with pembrolizumab (MK-3475) in patients with advanced solid tumors
por: Ayers, Mark, et al.
Publicado: (2015)

P1086: FAVEZELIMAB (ANTI–LAG-3) AND PEMBROLIZUMAB CO-BLOCKADE IN ANTI–PD-1–NAIVE PATIENTS WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA: AN OPEN-LABEL PHASE 1/2 STUDY
por: Gregory, G., et al.
Publicado: (2022)

LAG-3 and 4-1BB identify dysfunctional antigen-specific T cells in the tumor microenvironment and combinatorial LAG-3/4-1BB targeting gives synergistic tumor control
por: Williams, Jason B, et al.
Publicado: (2015)

Antigen presentation by tumor infiltrating B cells influences CD4 T cell phenotype and function in primary lung cancer patient tumors
por: Bruno, Tullia, et al.
Publicado: (2015)

P16-08. Combined blockade of the PD-1 and IL-10 pathways synergistically enhance HIV-specific CD4 T cell functions
por: Porichis, F, et al.
Publicado: (2009)

Use of preoperative breast MRI to determine disease extent
por: Dineen, Nicky, et al.
Publicado: (2015)

Preferential control of induced regulatory T cell homeostasis via a Bim/Bcl-2 axis
por: Wang, X, et al.
Publicado: (2012)

Pharmacological CCR1 blockade limits infarct size and preserves cardiac function in a chronic model of myocardial ischemia/reperfusion
por: Van de Sandt, A, et al.
Publicado: (2011)

Phase-lag return mappings for a 3 cell multifunctional central pattern generator
por: Wojcik, Jeremy, et al.
Publicado: (2012)

Zero-lag long-range synchronization of Hodgkin-Huxley neurons is enhanced by dynamical relaying
por: Vicente, Raul, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_jf1mgcc6k73s3f31n6k8eu5le1